Abstract:Liying Chen, 1, &ast Dingqi Lu, 2, &ast Kai Yu, 1 Shiya He, 1 Liu Liu, 1 Xvfeng Zhang, 1 Bo Feng, 3 Xinchang Wang 4 1 Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310053, People's Republic of China; 2 First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310053, People's Republic of China; 3 Department of Nephrology, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, Zhejiang Province, 314001, People's Republic of China; 4 Department of Rheumatology, The Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310005, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xinchang Wang Department of Rheumatology, The Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China Tel +86 13065714635 Email Purpose: Sjögren's syndrome (SS) is a systemic autoimmune disease mainly characterized by dysfunction of exocrine glands. Studies on diagnosis models specific for SS patients are very limited. We aimed to use gene expression datasets from salivary glands to identify aberrant differentially expressed genes (DEGs) and pathways by bioinformatics and validate candidate genes by clinical minor labial gland biopsy (MSGB) samples, and finally build a combined gene quantitative diagnosis model of SS. Patients and Methods: Original datasets GSE23117, GSE7451, and GSE127952 were obtained from the Gene Expression Omnibus database (GEO) and integrated and analyzed for differentially expressed genes in SS salivary glands. ClueGO and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of upregulated and downregulated DEGs were performed, and protein–protein interaction (PPI) networks were constructed using the STRING and Cytoscape database. H&E staining and immunohistochemistry were used to validate the expression levels of four hub genes in salivary glands. Finally, a receiver operating characteristic (ROC) curve of the combined diagnosis of four hub genes was analyzed in SS patients and non-SS patients in order to explore the diagnostic efficacy of these genes compared with conventional FS in SS. Results: Fifty-three upregulated genes and fifteen downregulated genes were identified. We analyzed the expression and function of four hub genes via H&E, immunohistochemistry, and ROC analysis. We then evaluated and verified the diagnosis value of four hub genes, STAT1, MNDA, IL10RA , and CCR1 in MSGB of SS and non-SS. A combined diagnosis model of four indicators was established to identify patients' discrete data on the foci size (AUC=0.915). Conclusion: The expression of STAT1, MNDA , and IL10RA may be potential biological indicators for SS diagnosis. Compared with FS, a combined diagnosis model of quantitative gene expression could potentially contribute to improving the sensitivity and specificity of MSGB of SS. Keywords: Sjogren's syndrome, bioinformatics analysis, hub genes, validation, diagnostic performance, focus score Graphical Sjogren's syndrome (SS) is a systemic autoimmune disease primarily characterized by epithelitis in exocrine glands and the development of specific antibodies to SSA/SSB. Europe, North America, and Asia have a wide range of incidence rates for SS, and the prevalence rate in the population of three continents is 60.82 persons per 100,000 inhabitants, 1 and the female versus male ratio is 14:1. Patients with SS typically present with dry mouth and eyes, joint pain, and fatigue. 2,3 50% of patients present with systemic damage, and they have a 10–20-fold increased risk of developing B cell lymphoma. 4 The etiology and pathogenesis of the characteristic progressive glandular dysfunction in SS have not been fully clarified. Genetic susceptibility, environmental factors, and immune disorders are thought to play a dominant role. Studies have found that susceptibility genes, such as human leukocyte antigen ( HLA ), Interferon Regulatory Factor 5 ( IRF5 ), BLK , Interleukin 12A ( IL12A ), TNFAIP3 interaction protein 1 ( TNIP1 ), and Chemokine receptor 5 ( CXCR5 ), are closely related to the occurrence of SS. 5 Activation of the type I interferon pathway, infiltration of T and B lymphocytes, and formation of ectopic germinal centers within salivary glands all cause damage in multiple tissues. 6 The histopathology of salivary glan -Abstract Truncated-

The Critical Biomarkers Identification of Insulin Signaling Involved in Initiating cAMP Signaling Mediated Salivary Secretion in Sjogren Syndrome: Transcriptome Sequencing in NOD Mice Model

[Effect of Prescriptions Replenishing Vital Essence, Tonifying Qi and Activating Blood on TNF-alpha, IL-1beta Expressions in Serum and Submaxillary Gland of NOD Mice with Sjogren's Syndrome].

Exploring the Target and Mechanism of Radix Paeoniae Alba on Sjogren’s Syndrome

Effects of Total Glucosides of Peony on AQP-5 and Its Mrna Expression in Submandibular Glands of NOD Mice with Sjogren's Syndrome.

Effect of Nourishing Yin, Strengthening Qi and Activating Blood Decoction on Fas/FasL in Salivary Glands of NOD Mice with Sjogren's Syndrome and Their Mrna Expression

Biomarkers for Primary Sjögren’s Syndrome

Detection of Salivary Protein Biomarkers of Saliva Secretion Disorder in a Primary Sjögren Syndrome Murine Model

Transcriptomic and Single-Cell Analysis Reveals Regulatory Networks and Cellular Heterogeneity in Mouse Primary Sjögren’s Syndrome Salivary Glands

Sphingosine-1-phosphate Alleviates Sjögren’s Syndrome-Like Symptoms Via Inducing Autophagy and Regulating Status of Treg Cells in NOD Mice

Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome

AB0020 Differentially Expressed Genes in Sjgren’s Syndrome Microarray

Bioinformatics Analysis for Identification of Key Genes in Salivary Gland and the Potential of a Combination of Biomarkers for the Diagnosis of SS

Transcriptomic and Network Analysis of Minor Salivary Glands of Patients With Primary Sjögren’s Syndrome

Advances in cellular and molecular pathways of salivary gland damage in Sjögren's syndrome

Qing Zao Fang (QZF) Alleviates the Inflammatory Microenvironment of the Submandibular Gland in Sjögren's Syndrome Based on the PI3K/Akt/HIF-1 α/VEGF Signaling Pathway

Altered characteristics of regulatory T cells in target tissues of Sjögren's syndrome in murine models

Endogenous IL-22 contributes to the pathogenesis of salivary gland dysfunction in the non-obese diabetic model of Sjögren's syndrome

Sialoadenitis Progression in Nonobese Diabetic Mice and Its Correlation with Expression of Apoptosis-Associated Proteins in Salivary Glands and Serum IgG Levels.

Lysosome-associated membrane protein 3 misexpression in salivary glands induces a Sjögren’s syndrome-like phenotype in mice

Dysregulated Ca2+ signaling, fluid secretion, and mitochondrial function in a mouse model of early Sjogrens syndrome

Expression of ICOS in the Salivary Glands of Patients with Primary Sjogren's Syndrome and Its Molecular Mechanism